-
Frontomaxillary facial angle in trisomy 21 fetuses at 16-24 weeks of gestation.
Molina F, Persico N, Borenstein M, Sonek J, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:384-7. -
Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:618-24. -
First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:493-50. -
Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Persico N, Kagan KO, Gazzoni A, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:5-11. -
Frontomaxillary facial angles in screening for trisomy 21 at 14-23 weeks gestation.
Sonek J, Borenstein M, Downing C, McKenna D, Neiger R, Croom C, Genrich T, Nicolaides KH.
Am J Obstet Gynecol 2007;197:160. -
Frontomaxillary facial angle in fetuses with trisomy 21 at 11+0-13+6 weeks.
Sonek J, Borenstein M, Dagklis T, Persico N, Nicolaides KH.
Am J Obstet Gynecol 2007;196:271. -
First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population.
Sonek J, Cicero S, Nicolaides K.
Am J Obstet Gynecol 2007;196:19. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Nasal bone assessment in prenatal screening for trisomy 21.
Sonek JD, Cicero S, Neiger R, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1219-30. -
Metopic suture in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks of gestation.
Faro C, Wegrzyn P, Benoit B, Chaoui R, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:286-9. -
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:151-5. -
Nasal bone in first-trimester screening for trisomy 21.
Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH.
Am J Obstet Gynecol 2006;195:109-14. -
Brachycephaly and frontal lobe hypoplasia in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Dagklis T, Csapo B, Sotiriadis A, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;28:870-5. -
Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness.
Vandecruys H, Faiola S, Auer M, Sebire N, Nicolaides KH.
Ultrasound Obstet Gynecol 2005;25:551-3. -
Detection of trisomy 21 by quantitative mass spectrometric analysis of single-nucleotide polymorphisms.
Tsui NB, Chiu RW, Ding C, El-Sheikhah A, Leung TN, Lau TK, Nicolaides KH, Lo YM.
Clin Chem 2005;51:2358-62. -
Increased nuchal translucency with normal karyotype.
Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH.
Am J Obstet Gynecol 2005;192:1005-21. -
Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O.
Ultrasound Obstet Gynecol 2005;25:221-6. -
Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21.
Nicolaides KH, Chervenak FA, McCullough LB, Avgidou K, Papageorghiou A.
Am J Obstet Gynecol 2005;193:322-6. -
Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan.
Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH.
Ultrasound Obstet Gynecol 2005;26:22-7. -
Down syndrome screening marker levels in women with a previous aneuploidy pregnancy.
Cuckle HS, Spencer K, Nicolaides KH.
Prenat Diagn 2005;25:47-50.